...
首页> 外文期刊>Medicine. >Transanal endoscopic microsurgery for advanced polyps and early cancers in the rectumLong-term outcome: A STROBE compliant observational study
【24h】

Transanal endoscopic microsurgery for advanced polyps and early cancers in the rectumLong-term outcome: A STROBE compliant observational study

机译:经肛门内窥镜显微外科手术治疗直肠中晚期息肉和早期癌症的长期结果:符合STROBE的观察性研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Transanal endoscopic microsurgery (TEM) allows for the resection of large adenomas and early stage cancers in the rectum. The rate of complications and recurrence for malignant tumors compared with benign tumors has been questioned.The objective of our study was to analyze the outcome after TEM procedures for adenomas and cancers with focus on local recurrence and complications.All 280 patients who had a TEM procedure between January 2008 and September 2015 were enrolled in a prospective cohort study. Outcome was described for benign and malignant tumors. Mortality, recurrence, and complications were recorded.Two hundred eighty tumors were treated with TEM, 176 (63%) were benign and 104 (37%) were malignant. Complication rates were significantly different in the 2 groups, 10.8% (n = 19) in the benign and 24.0% (n = 25) in the malignant group (P = 0.003). A significant difference in perforation/penetration to the peritoneal cavity was noted (P = 0.034). There were no significant difference in the recurrence rate of 8.3% (n = 13) in the benign and 9.0% (n = 7) in the malignant groups. Thirty days mortality rates were 1.1% in the benign group versus 1.9% in the malignant. Other complications were noted in 2.8% and 3.8% in the benign and malignant group, respectively.TEM seems to be a safe and viable procedure for removing both benign and malignant lesions from the rectum. TEM offers low mortality and complication rates also recurrence after resection of malignant tumors.
机译:经肛门内窥镜显微手术(TEM)可切除直肠中的大腺瘤和早期癌症。相对于良性肿瘤,恶性肿瘤的并发症和复发率受到质疑。在2008年1月至2015年9月之间进行了一项前瞻性队列研究。描述了良性和恶性肿瘤的结果。记录死亡率,复发率和并发症。TEM治疗280例,良性肿瘤176例(63%),恶性肿瘤104例(37%)。两组的并发症发生率显着不同,良性组为10.8%(n = 19),恶性组为24.0%(n = 25)(P = 0.003)。注意到腹膜腔穿孔/穿透的显着差异(P = 0.034)。良性组的复发率分别为8.3%(n = 13)和恶性组的9.0%(n = 7)没有显着差异。良性组的30天死亡率为1.1%,而恶性组为1.9%。良性和恶性组的其他并发症分别为2.8%和3.8%。透射电镜可降低死亡率,并发症率也可在恶性肿瘤切除后复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号